デフォルト表紙
市場調査レポート
商品コード
1726144

パイロジェン検査の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、セグメント別予測、2025年~2030年

Pyrogen Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Test Type (LAL Test, In Vitro Pyrogen Test, Rabbit Test), By End-use, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 140 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
パイロジェン検査の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、セグメント別予測、2025年~2030年
出版日: 2025年04月02日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

パイロジェン検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のパイロジェン検査市場規模は2030年までに24億9,000万米ドルに達すると予測されています。

同市場は2025~2030年にかけてCAGR 11.2%で成長すると予測されています。医薬品、バイオ医薬品、生物製剤を含む治療の需要増加が、予測期間中の市場成長を促進する主要因です。パイロジェンは、動物や人体に誘発されると発熱を引き起こす有毒な分子物質です。パイロジェン検査は、製薬、バイオ医薬品、バイオテクノロジー、医療機器企業がパイロジェンがないことを確認するために使用します。LAL、in vitroパイロジェン、ウサギ検査など様々な方法で製品の品質を保証しています。

慢性疾患の有病率の増加は、市場の成長を支えるもう一つの主要因です。慢性疾患の有病率は先進国では非常に高く、中国やインドを含む新興諸国でも高いペースで増加しています。不健康な食事、喫煙、飲酒、運動不足などのさまざまな要因が、がん、心血管疾患、糖尿病、慢性呼吸器疾患などの慢性疾患の発生につながっています。したがって、このような疾患の治療のための治療や医療機器に対する需要が高まっており、その結果、医薬品や医療機器を含む製品の品質を保証するためのパイロジェン検査に対する需要が高まると予測されます。

パイロジェン検査市場レポートハイライト

  • パイロジェン検査キットと試薬の大規模なアプリケーションとその反復購入により、消耗品は2024年にこの市場で最大の収益を上げるセグメントでした。
  • 市場セグメンテーションは、医薬品、生物製剤、治療・診断用医療機器の需要の高まりにより、2024年に顕著なシェアを占めました。
  • 製薬・バイオテクノロジー企業セグメントは、治療の大量生産と医薬品開発のための企業による研究開発投資の増加により、2024年の収益でパイロジェン検査市場を独占しました。
  • 北米は主要地域市場であり、2024年に最大の収益シェアを占めたが、これは主にこの地域に医薬品や医療機器を含む多数の医療企業が存在するためです。
  • アジア太平洋は、調査期間中に最も急成長する市場と予測されています。インドや中国を含むアジア諸国における慢性疾患の有病率の増加が、同地域の市場拡大に寄与する主要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 パイロジェン検査市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • パイロジェン検査市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
    • 価格分析

第4章 パイロジェン検査市場:製品別、推定・動向分析

  • 製品市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 世界のパイロジェン検査市場:製品別展望
  • 2018~2030年の市場規模と予測と動向分析
    • 消耗品
    • 機器
    • サービス

第5章 パイロジェン検査市場:検査タイプ別、推定・動向分析

  • 検査タイプ市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 世界のパイロジェン検査市場:検査タイプ別展望
  • 2018~2030年の市場規模と予測と動向分析
    • LALテスト
    • 検査管内パイロジェン検査
    • ウサギテスト

第6章 パイロジェン検査市場:最終用途別、推定・動向分析

  • 最終用途市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 世界のパイロジェン検査市場:最終用途別展望
  • 2018~2030年の市場規模と予測と動向分析
    • 製薬・バイオテクノロジー企業
    • 医療機器企業
    • その他

第7章 パイロジェン検査市場:地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測、動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
  • 企業プロファイル
    • Charles River Laboratories
    • Novo Nordisk
    • Merck KGaA
    • GenScript
    • bioMerieux SA
    • Lonza
    • Thermo Fisher Scientific, Inc.
    • Seikagaku Biobusiness Corporation
    • FUJIFILM Wako Chemicals USA Corporation(Pyrostar)
    • MiCAN Technologies Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America pyrogen testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America pyrogen testing market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 5 North America LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 6 North America in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 7 North America pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. pyrogen testing market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 10 U.S. LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 11 U.S. in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 12 U.S. pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada pyrogen testing market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 15 Canada LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 16 Canada in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 17 Canada pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Mexico pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 19 Mexico pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 20 Mexico LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 21 Mexico in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 22 Mexico pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe pyrogen testing market, by region, 2018 - 2030 (USD Million)
  • Table 24 Europe pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 25 Europe pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 26 Europe LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 27 Europe in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 28 Europe pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 31 Germany LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 32 Germany in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 33 Germany pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 UK pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 UK pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 36 UK LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 37 UK in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 38 UK pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 France pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 40 France pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 41 France LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 42 France in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 43 France pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Italy pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Italy pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 46 Italy LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 47 Italy in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 48 Italy pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Spain pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Spain pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 51 Spain LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 52 Spain in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 53 Spain pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Denmark pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 55 Denmark pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 56 Denmark LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 57 Denmark in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 58 Denmark pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Sweden pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 Sweden pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 61 Sweden LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 62 Sweden in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 63 Sweden pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Norway pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 65 Norway pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 66 Norway LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 67 Norway in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 68 Norway pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific pyrogen testing market, by region, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 72 Asia Pacific LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 73 Asia Pacific in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 74 Asia Pacific pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 China pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 76 China pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 77 China LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 78 China in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 79 China pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Japan pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 81 Japan pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 82 Japan LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 83 Japan in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 84 Japan pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 India pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 India pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 87 India LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 88 India in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 89 India pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 South Korea pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 91 South Korea pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 92 South Korea LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 93 South Korea in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 94 South Korea pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Australia pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 96 Australia pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 97 Australia LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 98 Australia in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 99 Australia pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Thailand pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 101 Thailand pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 102 Thailand LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 103 Thailand in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 104 Thailand pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Latin America pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 106 Latin America pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 107 Latin America LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 108 Latin America in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 109 Latin America pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 110 Brazil pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 111 Brazil pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 112 Brazil LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 113 Brazil in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 114 Brazil pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Argentina pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 116 Argentina pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 117 Argentina LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 118 Argentina in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 119 Argentina pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 120 MEA pyrogen testing market, by region, 2018 - 2030 (USD Million)
  • Table 121 MEA pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 122 MEA pyrogen testing market, by test type, (USD Million Number of Tests in Thousands) 2018 - 2030
  • Table 123 MEA LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 124 MEA in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 125 MEA pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 126 South Africa pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 127 South Africa pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 128 South Africa LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 129 South Africa in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 130 South Africa pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia pyrogen testing market, by test type, Number of Tests in Thousands) 2018 - 2030
  • Table 133 Saudi Arabia LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 134 Saudi Arabia in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 135 Saudi Arabia pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 136 UAE pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 137 UAE pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018 - 2030
  • Table 138 UAE LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 139 UAE in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 140 UAE pyrogen testing market, by end use, 2018 - 2030 (USD Million)
  • Table 141 Kuwait pyrogen testing market, by product, 2018 - 2030 (USD Million)
  • Table 142 Kuwait pyrogen testing market, by test type, 2018 - 2030 (Number of Tests in Thousands)
  • Table 143 Kuwait LAL test market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 144 Kuwait in vitro pyrogen testing market, by type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 145 Kuwait pyrogen testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Pyrogen testing market: market outlook
  • Fig. 14 Pyrogen testing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Pyrogen testing market driver impact
  • Fig. 20 Pyrogen testing market restraint impact
  • Fig. 21 Pyrogen testing market strategic initiatives analysis
  • Fig. 22 Pyrogen testing market: Product movement analysis
  • Fig. 23 Pyrogen testing market: Product outlook and key takeaways
  • Fig. 24 Consumables market estimates and forecast, 2018 - 2030
  • Fig. 25 Instruments estimates and forecast, 2018 - 2030
  • Fig. 26 Services market estimates and forecast, 2018 - 2030
  • Fig. 27 Pyrogen testing market: Test type movement analysis
  • Fig. 28 Pyrogen testing market: Test type outlook and key takeaways
  • Fig. 29 LAL test market estimates and forecast, 2018 - 2030
  • Fig. 30 Chromogenic test estimates and forecast, 2018 - 2030
  • Fig. 31 Turbidimetric test market estimates and forecast, 2018 - 2030
  • Fig. 32 Gel clot test market estimates and forecast, 2018 - 2030
  • Fig. 33 In vitro pyrogen test estimates and forecast, 2018 - 2030
  • Fig. 34 Monocyte Activation Test (MAT) market estimates and forecast, 2018 - 2030
  • Fig. 35 Recombinant Factor C (rFC) testing market estimates and forecast, 2018 - 2030
  • Fig. 36 Rabbit test market estimates and forecast, 2018 - 2030
  • Fig. 37 Pyrogen testing Market: End use movement Analysis
  • Fig. 38 Pyrogen testing market: End use outlook and key takeaways
  • Fig. 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 40 Medical devices companies market estimates and forecasts,2018 - 2030
  • Fig. 41 Others market estimates and forecasts,2018 - 2030
  • Fig. 42 Global pyrogen testing market: Regional movement analysis
  • Fig. 43 Global pyrogen testing market: Regional outlook and key takeaways
  • Fig. 44 Global pyrogen testing market share and leading players
  • Fig. 45 North America market share and leading players
  • Fig. 46 Europe market share and leading players
  • Fig. 47 Asia Pacific market share and leading players
  • Fig. 48 Latin America market share and leading players
  • Fig. 49 Middle East & Africa market share and leading players
  • Fig. 50 North America, by country
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030
  • Fig. 52 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK market estimates and forecasts, 2018 - 2030
  • Fig. 57 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 58 France market estimates and forecasts, 2018 - 2030
  • Fig. 59 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 60 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 65 China market estimates and forecasts, 2018 - 2030
  • Fig. 66 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 67 India market estimates and forecasts, 2018 - 2030
  • Fig. 68 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 69 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 70 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 71 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 72 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 78 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 79 Market share of key market players - Pyrogen testing market
目次
Product Code: GVR-1-68038-706-3

Pyrogen Testing Market Growth & Trends:

The global pyrogen testing market size is anticipated to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.2% from 2025 to 2030. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels the growth of the market during the forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in an animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases is another foremost factor supporting market growth. The prevalence of chronic diseases is very high in developed countries and is growing at a high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise lead to the occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases. Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

Pyrogen Testing Market Report Highlights:

  • Consumables was the largest revenue grossing segment of this market in 2024, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase.
  • Instruments segment accounted for the remarkable share in the market in 2024 and is also expected to showcase significant growth during the forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis.
  • The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2024, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development.
  • North America is the leading regional market and accounted for the largest revenue share in 2024 primarily due to the existence of a large number of healthcare companies including pharmaceuticals and medical devices in this region.
  • The Asia Pacific region is anticipated to be the fastest-growing market during the study period. The growing prevalence rate of chronic diseases in Asian countries including India and China is a major factor contributing to the expansion of the market in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Test type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pyrogen Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for therapeutic drugs
      • 3.2.1.2. Growing investment in R&D
      • 3.2.1.3. Increasing prevalence of chronic disease
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent government regulations
  • 3.3. Pyrogen Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Pyrogen Testing Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Pyrogen Testing Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Consumables
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pyrogen Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. Test Type Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Pyrogen Testing Market by Test Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. LAL test
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.2. Chromogenic test
        • 5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
      • 5.4.1.3. Turbidimetric test
        • 5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
      • 5.4.1.4. Gel clot test
        • 5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
    • 5.4.2. In vitro pyrogen test
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
      • 5.4.2.2. Recombinant Factor C (rFC) testing
        • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
      • 5.4.2.3. Monocyte Activation Test (MAT)
        • 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 5.4.3. Rabbit test
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)

Chapter 6. Pyrogen Testing Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Pyrogen Testing Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Pharmaceutical & biotechnology companies
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Medical devices companies
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Pyrogen Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Charles River Laboratories
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Novo Nordisk
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. bioMerieux SA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Lonza
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Seikagaku Biobusiness Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. MiCAN Technologies Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives